Compare IOVA & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | NCMI |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 414.7M |
| IPO Year | 2008 | 2006 |
| Metric | IOVA | NCMI |
|---|---|---|
| Price | $3.69 | $3.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $9.11 | $5.63 |
| AVG Volume (30 Days) | ★ 17.4M | 532.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.74% |
| EPS Growth | 14.84 | ★ 52.17 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.55 | $11.13 |
| Revenue Next Year | $37.55 | $7.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.64 | $3.17 |
| 52 Week High | $5.63 | $6.18 |
| Indicator | IOVA | NCMI |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 35.81 |
| Support Level | $2.02 | N/A |
| Resistance Level | $4.34 | $3.90 |
| Average True Range (ATR) | 0.36 | 0.13 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 14.51 | 0.00 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.